The Impact of the "Stone MD" Mobile App on the Prevention of Forgotten

Status Recruiting

Clinical Trial Summary

The Impact of the "Stone MD" Mobile App on the Prevention of Forgotten Ureteral Stents

Clinical Trial Description

Inclusion Criteria: 1. Male and female patients aged 18 to 80 years who have a Ch 4.7-6.0 polyurethane ureteral stent Exclusion Criteria: 1. Active phase of urinary tract infection 2. Insufficient level of social adaptation 3. The patient does not have a smartphone with Internet access All patients will be randomized into 2 groups: - group A - patients who used the Stone MD mobile application - group B - patients who did not use the mobile application Patients are to be assigned a randomization number that will match their treatment. Block randomization using 10 blocks is to be performed by a central randomization organization (www.randomize.net) using a computerized algorithm. "Stent Radar" - part of the "Stone MD" mobile application. This tool is designed for the patient to remove the ureteral stent using a mobile application within the time period prescribed by the doctor. After the operation, the patient independently enters the data related to the installation of the stent in the Stent Radar section of the Stone MD mobile application. This data includes: the name of the stent, the side of insertion, and the estimated date of removal. In a few days, a push notification appears in the application stating that it is necessary to consult a doctor for the timely removal of the stent. Thus, it is almost impossible to forget to remove the stent. At discharge, we strongly recommend that all patients install the Stone MD mobile app on their smartphone. In the postoperative period, all patients will be monitored. In the event that 2 weeks after the expected date of removal, the patient does not get in touch, he will receive a call from the clinic, reminding him of the necessary visit (to remove the stent). Primary assessed outcomes: 1. Number of patients who removed the stent on time in both groups 2. Number of patients who delayed stent removal in both groups (less than 14 days) 3. Number of patients who forgot to remove the stent in both groups (removed the stent more than 14 days from the expected date of removal) Secondary assessed outcomes: 1. Assessment of Stone-free status after surgery by performing computed tomography of kidneys and urinary tract without intravenous contrasting 1 month after surgery ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06022952
Study type	Interventional
Source	St. Petersburg State Pavlov Medical University
Contact
Status	Recruiting
Phase	N/A
Start date	February 1, 2023
Completion date	December 1, 2023

View Details

See also
Status	Clinical Trial	Phase
Enrolling by invitation	`NCT04746378` - PRedictive Accuracy of Initial Stone Burden Evaluation.
Recruiting	`NCT05100017` - Methocarbamol vs Oxybutynin for Management of Pain and Discomfort S/P Ureteroscopy Procedure	N/A
Recruiting	`NCT04021381` - Citrate Salts for Stone-free Result After Flexible Ureterorenoscopy for Inferior Calyx Calculi	Phase 3
Completed	`NCT02266381` - A Prospective Comparison of Fluoroscopic, Sonographic or Combined Approach for Renal Access in Percutaneous Nephrolithotomy	N/A
Completed	`NCT01451931` - Study of Tomography of Nephrolithiasis Evaluation	Phase 4
Terminated	`NCT01431378` - Pilot Study of Model Based Iterative Reconstruction Using 64-Slice	N/A
Completed	`NCT02895711` - Radiation Dose of Pediatric Patients During Ureteroscopy
Completed	`NCT01295879` - Vitamin D Repletion in Stone Formers With Hypercalciuria	Phase 4
Completed	`NCT05340075` - Staged Bilateral Percutaneous Nephrolithotomy
Recruiting	`NCT03919227` - Measurement of Resistance During UAS Insertion Procedure in RIRS	N/A
Recruiting	`NCT03717285` - Under Direct Vision vs Under Non Direct Vision of Insertion of UAS in RIRS	N/A
Completed	`NCT05340088` - Optimal Passive Dilation Time in Retrograde Intrarenal Surgery
Completed	`NCT05032287` - Medical Expulsive Therapy Post-SWL For Renal Stones	N/A
Recruiting	`NCT05701098` - SOUND Pivotal Trial - (Sonomotion stOne comminUtion resoNance ultrasounD)	N/A
Not yet recruiting	`NCT04080973` - Metabolic Workup in Patients Suffering From Kidney Stone Disease and Osteopenia	N/A
Terminated	`NCT01736358` - The Use of Intranasal Ketoralac for Pain Management (Sprix)	Phase 4
Completed	`NCT01792765` - Management of Ureteral Calculi Using Ultrasound Guidance: A Radiation Free Approach	N/A
Completed	`NCT06211842` - Genetic Variations That Increase the Risk for Calcium Kidney Stones: a Family-based Study
Not yet recruiting	`NCT02214836` - Ultrasound Imaging of Kidney Stones and Lithotripsy	N/A
Not yet recruiting	`NCT04606758` - Fluoroscopic Guided vs US-guided Percutaneous Nephrolithotripsy for the Treatment of Stone Disease	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.